ANIK

ANIK

USD

Anika Therapeutics Inc. Common Stock

$9.630-0.040 (-0.414%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$9.670

Hoch

$9.850

Tief

$9.400

Volumen

0.26M

Unternehmensfundamentaldaten

Marktkapitalisierung

138.8M

Branche

Drug Manufacturers - Specialty & Generic

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

0.10M

Börse

NMS

Währung

USD

52-Wochen-Spanne

Tief $7.87Aktuell $9.630Hoch $18.37

Ähnliche Nachrichten

Analyst Upgrades

Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $15 Price Target

Barrington Research analyst Michael Petusky maintains Anika Therapeutics with a Outperform and maintains $15 price target.

Mehr anzeigen
Barrington Research Maintains Outperform on Anika Therapeutics, Maintains $15 Price Target
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

Mehr anzeigen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK
PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ: ANIK). Such investors...

Mehr anzeigen
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK